PenkeTrading
Posted - 2 days ago
I found you an Oversold RSI (Relative Strength Index) on the daily chart of Astria Therapeutics Inc. Is that bullish or bearish? $ATXS #Astria #RsiOversold #NASDAQ
Elisabeth0Mercado
Posted - 6 days ago
$YMAB $ATXS MYNZ Wow, this is insane news! Don't miss out. The train is leaving the station. Add it to your watchlist to see what happens next. 😏
Thestocktraderhubzee
Posted - 6 days ago
WATCHLIST NOV 15 2024..
$ATXS HC Wainwright & Co. Reiterates Buy on Astria Therapeutics, Maintains $16 Price Target
$CSCO Citigroup Maintains Buy on Cisco Systems, Raises Price Target to $64
$XFOR HC Wainwright & Co. Maintains Buy on X4 Pharmaceuticals, Lowers Price Target to $1.5
$SNCY Barclays Maintains Overweight on Sun Country Airlines, Raises Price Target to $24
$JBLU Barclays Maintains Underweight on JetBlue Airways, Raises Price Target to $7
ChessGM
Posted - 2 weeks ago
$ATXS Heads up alert! Upcoming earnings on Monday, 11/11/2024 for $ATXS Neutral (5.5) In reviewing the recent developments surrounding Astria Therapeutics, Inc. (Nasdaq: ATXS), the company appears to be navigating a critical phase in its growth trajectory. Key financial metrics indicate that while the firm remains in the early stages of its product pipeline, it is making significant strides in securing regulatory designations and preparing for upcoming presentations that could enhance its visibility in the biopharmaceutical landscape. The stock currently trades with a P/E ratio that suggests it is not yet generating profits, typical for companies in its phase. However, the anticipation surrounding navenibart's Orphan Drug Designation and European Commission's OMPD could drive investor interest. Analysts project a substantial increase in EPS as clinical results from ongoing trials, such as the ALPHA-STAR trial, are expected to be released, which may provide insights into the drug's efficacy and market potential. Revenue forecasts remain speculative but optimistic, contingent upon successful trial outcomes and subsequent approvals. Looking ahead, the upcoming earnings report is expected to highlight the company's progress in clinical trials and any advancements in regulatory approvals. Historical performance indicates that Astria has maintained a steady pace in its development pipeline, with the consensus estimate for this quarter leaning towards a loss per share, in line with previous quarters. Analysts anticipate that the focus will be on updates regarding navenibart’s clinical efficacy and strategic partnerships that could bolster its market position. As such, the stock's performance may hinge on the sentiment generated by these developments, with analysts closely monitoring the interim results to gauge investor confidence moving forward. The consensus forecasts suggest a cautious optimism, but any significant deviation from expected outcomes could lead to volatility in the stock's valuation. - Funds were net buyers of $ATXS during the previous reporting quarter. - Top 5 funds with large holdings in $ATXS: * Perceptive Advisors LLC $59MM. New position. CGMFundRank: 57%, Fund Website: www.perceptivelife.com * RA Capital Management LLC $46MM. New position. CGMFundRank: 61%, Fund Website: www.racap.com * Adage Capital P $7MM. New position. CGMFundRank: 87%, Fund Website: www.adagecapital.com * Nantahala Capital Management LLC $6MM. New position. CGMFundRank: 70%, Fund Website: www.nantahalapartners.com * Sio Capital Management LLC $5MM. New position. CGMFundRank: 56%, Fund Website: www.siocapital.com - Last 10 days performance: -2% - Last 30 days performance: 6% - Last 90 days performance: 25% Follow ChessGM on stocktwits.com to get timely earnings alerts. Not a financial advice. Not a trading signal.
Shlobby
Posted - 10/24/24
$ATXS
Shlobby
Posted - 10/24/24
$ATXS getting tight
S_Franconi
Posted - 1 month ago
$ATXS Astria Therapeutics to Present at Upcoming American College of Allergy, Asthma, and Immunology Annual Scientific Meeting Oct 25th
S_Franconi
Posted - 1 month ago
$ATXS @G101SPM Can you run this one?
briefingcom
Posted - 1 month ago
$ATXS: Astria Therapeutics announces that the European Commission has granted Orphan Medicinal Product Designation to navenibart for the treatment of hereditary angioedema https://www.briefing.com/in-depth-analysis/content/article?ArticleId=IN20241016080841ATXS&utm_campaign=inplay&utm_medium=social&utm_source=st&utm_content=view_page
Doozio
Posted - 1 month ago
$ATXS 🍿. Mmmmkay bahhhhdy!! At least a 🧠👀 is da FUTUre of 🧠⏰ which is NOW during 🧠⏰♾️
therealinvestor
Posted - 09/26/24
$ATXS Huge bull flag on the daily. Hmm…
Botanical_Brian
Posted - 09/25/24
$ATXS out starting @ 11.20 down to 10.90
+$6,137.45
thx for the chips
Botanical_Brian
Posted - 09/25/24
$ATXS shorted 9,000 shares this am with avg cost $11.77
theboss1
Posted - 09/24/24
$ATXS is this anything? Or just insignificant share move?!
BioRich
Posted - 2 months ago
$ATXS
PenkeTrading
Posted - 2 months ago
I found you a Morning Star Candle Pattern on the daily chart of Astria Therapeutics Inc. $ATXS #Astria #MorningStar #NASDAQ
Stock_Titan
Posted - 3 months ago
$ATXS Astria Therapeutics Reports Second Quarter 2024 Financial Results and Provides a Corporate Update
https://www.stocktitan.net/news/ATXS/astria-therapeutics-reports-second-quarter-2024-financial-results-b23l4k3jlmhk.html
Stock_Titan
Posted - 3 months ago
$ATXS Astria Therapeutics Chooses Ypsomed’s YpsoMate as the Injection Device for STAR-0215 for the Treatment of Hereditary Angioedema
https://www.stocktitan.net/news/ATXS/astria-therapeutics-chooses-ypsomed-s-ypso-mate-as-the-injection-xa0ghxrlt6vb.html
NVDAMillionaire
Posted - 07/30/24
$ATXS Astria Therapeutics, Inc. (ATXS): A Promising Biopharmaceutical Company Advancing Novel Therapies for Allergic and Immunological Diseases http://beyondspx.com/2024/07/30/astria-therapeutics-inc-atxs-a-promising-biopharmaceutical-company-advancing-novel-therapies-for-allergic-and-immunological-diseases/
MarkettMaven
Posted - 4 months ago
$MAXN $RMBL $ATXS ⭐️Top gainers on our yesterday’s watchlist. 👉🏼Follow us to never miss on the next big move.
HeadRush
Posted - 4 months ago
$ATXS Good news inbound?
Lord_Monsoon
Posted - 4 months ago
$ATXS do we have some news driving the price back up?
TickerDD_com
Posted - 4 months ago
From 6/14/2024, looking back across 21 Month-Ends for ATXS, Percentage Change of Average Monthly Price had More Positives (55%) while Percentage Change of Average Monthly Volume had All Positives (100%) $ATXS #ATXS #ATXSStock #TickerDD #ATXSPrice https://www.youtube.com/watch?v=-Qeaa_y3RjI
kubota2323
Posted - 06/24/24
$ATXS adding
AnaChart
Posted - 6 months ago
$ATXS
https://anachart.com/wp-content/uploads/ana_temp/1716292987_soc-img.jpg
G101SPM
Posted - 6 months ago
#SHOWTIME American Thoracic Society Conference (May 16-21) Scheduled to appear: $BIAF,$ KYMR Society for Investigative Dermatology Meeting (May 16-17) Scheduled to appear: $PHIO, $ATXS, $VYNE, $AZTR
Stock_Titan
Posted - 6 months ago
$ATXS Astria Therapeutics Reports First Quarter 2024 Financial Results and Provides a Corporate Update
https://www.stocktitan.net/news/ATXS/astria-therapeutics-reports-first-quarter-2024-financial-results-and-9dj270hi5uwf.html
BillRayValentine
Posted - 6 months ago
$ATXS Excellent. Nobody is here yet.! I love it.
BillRayValentine
Posted - 6 months ago
$ATXS $9.24 Entry